The role of focal adhesion kinase (FAK) signalling in tumourigenesis and tumour progression has been extensively researched and has led to the development of FAK tyrosine kinase inhibitors as potential anticancer drugs [20]. The gene discussed is PTK2; the disease is neoplasm.